The burden of respiratory syncytial virus infection in young children - Test2 - elhamkhani - TriplyDB

The burden of respiratory syncytial virus infection in young children

The burden of respiratory syncytial virus infection in young children

http://www.wikidata.org/entity/Q34938343

about

Bronchodilators for bronchiolitis Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children High-flow nasal cannula therapy for infants with bronchiolitis Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months High-flow nasal cannula therapy for infants with bronchiolitis Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children Nebulised deoxyribonuclease for viral bronchiolitis in infants Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK Best practice in the prevention and management of paediatric respiratory syncytial virus infection Prenatal Alcohol Exposure and the Developing Immune System Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease Hypertonic saline (HS) for acute bronchiolitis: Systematic review and meta-analysis Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients Social, economic, and health impact of the respiratory syncytial virus: a systematic search Maternal immunization The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease T cell-mediated host immune defenses in the lung Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology

P2860

Q24193936-DBC50EC2-6B5F-4791-B587-3B8E8978EE46 Q24197915-561D2049-FB38-4677-BBCF-7FF535A6D541 Q24201071-45BAF822-F16C-4768-8E60-B93BF6CC14E6 Q24202863-25960D3D-2701-45BC-A93C-49D97A0B8EE5 Q24203800-ACA50003-C38E-40BC-81CD-B1731E3DCC08 Q24234622-3790A5A5-BDC2-4B26-AD2A-6BAED2D95BB7 Q24239887-398EAF23-23D2-4AC6-B250-350CB7BD7DB1 Q24624543-F8EBBB9B-0588-42E6-A648-CAD20994F70E Q24658528-36C98164-4593-4297-AC24-C0B75E0B0B6C Q26749036-5AB03E27-D901-41F9-B64A-1BE330F5194E Q26773220-C1413213-012E-4487-B6A2-768DF6FBB9B8 Q26774881-1947E26C-AB54-4A5C-88A4-B7DD60F0EBB5 Q26775152-731D923F-AFF8-45E6-B183-2E1F24D4228B Q26776447-49DCD5F4-3F43-42F4-89C0-332931D9FDBF Q26782086-FC50AA3D-A377-4071-80D5-1696683AA6B3 Q26782411-0777C2B9-A4FE-4B02-A990-55D2FF31E99B Q26829188-95A65373-E996-44CC-A1DB-BB9CCE308AFC Q26852865-8E53115B-DE3F-429C-951A-BAC97BFBDC38 Q26853746-A198229F-269F-41D7-88C8-B5656BE435C3 Q26864494-6981B2C9-A2DE-4AE6-A4D0-D2476D0B11A6 Q27010165-473C8642-7F5E-401C-9F2F-B3D018526C24 Q27021304-DFE754AD-E0AA-4549-9BCE-5B44B47841CD Q27027386-989D6DCC-AC98-416E-8AB6-35ECCD38B676 Q27303940-BB1DE040-5FAC-41F2-B2E4-C197C20663ED Q27311290-F6E46889-49D8-46FA-B708-62BB1ACC2C4A Q27329785-3A36634D-C9E9-4247-9E5D-E3466AC8FE51 Q27334724-EBC6B92B-F54B-40FB-BD0F-5E98AD1235E2 Q27664797-437EF6D6-AD14-4D08-ADED-D85F2AB4C478 Q27667750-0A9C2E2B-A26E-4B1B-8D4D-58677E99B993 Q27677570-AAA938FB-BA44-4DAB-AB34-AC765E9F221B Q28069415-BF29F3E5-D090-4C7C-BB83-1BC352BE7124 Q28071857-CA5DEA54-B133-48ED-BCFE-A905B85F3FDC Q28072535-1FAA7140-BAF1-4A9B-B4AD-598DEA845123 Q28395374-68AA03C0-56D3-45B9-A500-2C88B3D53E7D Q28548547-9EC2AD6A-133E-4440-9215-AABE02DA4BEE Q28551865-CF044337-0874-4C97-AF16-64AF6587C60F Q28551925-4ADB8A35-9B41-4897-BA0A-4E87DBE192EC Q28552644-D15649CE-0590-4CB8-922B-3D965EAF5DC2 Q28595695-25A02A20-0922-40BD-ADDE-32731959F2E1 Q28728377-5D65547C-A9A2-4793-8A06-E88AC5185D85

P2860

The burden of respiratory syncytial virus infection in young children

http://www.wikidata.org/entity/Q34938343

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

The burden of respiratory syncytial virus infection in young children

@ast

The burden of respiratory syncytial virus infection in young children

@en

The burden of respiratory syncytial virus infection in young children

@nl

type

label

The burden of respiratory syncytial virus infection in young children

@ast

The burden of respiratory syncytial virus infection in young children

@en

The burden of respiratory syncytial virus infection in young children

@nl

prefLabel

The burden of respiratory syncytial virus infection in young children

@ast

The burden of respiratory syncytial virus infection in young children

@en

The burden of respiratory syncytial virus infection in young children

@nl

P1433

Q34938343-73171914-E8CF-441B-8C22-A025002A2CC2

P1476

Q34938343-828759C4-195B-4C8C-89F8-4867920866EF

P2093

Q34938343-02835695-EFF1-44C7-BFE4-A91A5D51FB7C

Q34938343-2B7D4A62-4027-40CB-91B5-FBDC56EF2712

Q34938343-311AD169-173D-4F60-B548-4BCF02835222

Q34938343-58813AF7-FB95-40B9-90C6-7590AF8FF4D1

Q34938343-8F70B5C1-2AA1-45FF-BB6D-C8CFAAA74A32

Q34938343-9F9C5EAE-005B-41E1-BB2D-DE10EE5BAEB5

Q34938343-B0196A96-FA2E-4923-9BDB-908709BAE328

Q34938343-B10A5443-43F8-4B68-B138-2D3472BF40F9

Q34938343-CE9671B8-63E4-4DAD-914E-C3A46E3ECFFD

Q34938343-E440C21B-BC63-46F5-A962-33781AB8DD3A

P2860

Q34938343-09B574EC-8581-4F78-B0B5-FEB4FB49D782

Q34938343-214B0345-10AE-4BD2-9EBF-A728F8B3C0B6

Q34938343-27AE7E12-3B13-4FDA-AF53-C5AE6FA1595A

Q34938343-2928FCA4-62CB-4F60-9C69-D189CA996AD1

Q34938343-2F1B4D91-319C-4F72-9054-EA4EB6731689

Q34938343-4355C419-D548-434C-BD8E-B00212B96A32

Q34938343-4431ACCD-748F-43D9-AD8B-3A65C28FF885

Q34938343-4756FC7E-50FF-453A-888E-19D5D39DF8FC

Q34938343-47CCC97A-130B-44B9-8F60-3EB59A3FE7B3

Q34938343-485AF53F-F5F4-4358-9D62-9CF9FAD20A32

P304

Q34938343-B918A2F0-8EC0-463F-A38B-519134C2A666

P31

Q34938343-4E38CE32-044D-45EF-A186-4BDA6DB6AD33

P356

Q34938343-65937CF0-F7F7-4304-9BD0-FE10894DD0B9

P407

Q34938343-1B4453A9-7B79-4AEF-B7ED-BFE2BB53AC93

P433

Q34938343-C5926C93-6BFC-426A-BAA4-B05D4EA8AE50

P478

Q34938343-73D6DE05-D9E4-4F19-9894-3D750735985A

P50

Q34938343-7B26D56C-3253-43DE-A538-FD64761B215D

Q34938343-849E4C7F-4E28-4F5A-B3FA-86E149CE2D52

P577

Q34938343-8E1CA8BB-7B9A-4D9D-AE54-2E4CCF7E0789

P698

Q34938343-6FF299D1-9CE1-4016-A8EF-BFFCD3D11E64

P932

Q34938343-F0BA02A1-9D81-4A83-961E-A290EF55BCF8

P356

P1433

The New England Journal of Medicine

P1476

The burden of respiratory syncytial virus infection in young children

@en

P2093

Aaron K Blumkin

http://www.w3.org/2001/XMLSchema#string

Carlos G Grijalva

http://www.w3.org/2001/XMLSchema#string

Caroline Breese Hall

http://www.w3.org/2001/XMLSchema#string

Geoffrey A Weinberg

http://www.w3.org/2001/XMLSchema#string

Katherine A Poehling

http://www.w3.org/2001/XMLSchema#string

Marie R Griffin

http://www.w3.org/2001/XMLSchema#string

Marika K Iwane

http://www.w3.org/2001/XMLSchema#string

Mary A Staat

http://www.w3.org/2001/XMLSchema#string

Peggy Auinger

http://www.w3.org/2001/XMLSchema#string

Peter Szilagyi

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality associated with influenza and respiratory syncytial virus in the United States

Respiratory syncytial virus and parainfluenza virus.

Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.

Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease.

Respiratory syncytial virus infection: therapy and prevention.

Human metapneumovirus infection among children hospitalized with acute respiratory illness.

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics.

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

P304

588-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0804877

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn M. Edwards

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19196675

http://www.w3.org/2001/XMLSchema#string

P932

4829966

http://www.w3.org/2001/XMLSchema#string